Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Blinded Multi-center Clinical Trial to Evaluate the Efficacy of the Recently FDA Approved RPS Adeno Detector for Detecting Adenoviral Conjunctivitis

NCT00266734 is registered in ClinicalTrials.gov with Rapid Pathogen Screening as lead sponsor.

NCT NCT00266734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00266734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Blinded Multi-center Clinical Trial to Evaluate the Efficacy of the Recently FDA Approved RPS Adeno Detector for Detecting Adenoviral Conjunctivitis
Lead sponsor
Rapid Pathogen Screening
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2004
Completion date
September 30, 2005
Enrollment
186
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute conjunctivitis, adenoviral conjunctivitis